AxoGen Inc (AXGN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 5.78 is considered Overvalued compared with the five-year average of -6.14. The fair price of AxoGen Inc (AXGN) is between 10.31 to 21.48 according to relative valuation method. Compared to the current price of 30.65 USD , AxoGen Inc By Overvalued By 42.7%.

Relative Value

Fair Zone

10.31-21.48

Current Price：30.65

42.7%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is AxoGen Inc (AXGN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

AxoGen Inc (AXGN) has a current Price-to-Book (P/B) ratio of 11.83. Compared to its 3-year average P/B ratio of 5.14, the current P/B ratio is approximately 130.04% higher. Relative to its 5-year average P/B ratio of 4.97, the current P/B ratio is about 137.88% higher. AxoGen Inc (AXGN) has a Forward Free Cash Flow (FCF) yield of approximately 0.23%. Compared to its 3-year average FCF yield of -4.17%, the current FCF yield is approximately -105.60% lower. Relative to its 5-year average FCF yield of -5.79%, the current FCF yield is about -104.04% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AXGN competitors is 2.34, providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN.O) exhibits a P/S ratio of 5.78, which is 147.63% above the industry average. Given its robust revenue growth of 21.25%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AXGN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AXGN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AXGN currently overvalued or undervalued?

What is AxoGen Inc (AXGN) fair value?

AXGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of AxoGen Inc (AXGN) is between 10.31 to 21.48 according to relative valuation method.

How does AXGN's valuation metrics compare to the industry average?

The average P/S ratio for AXGN's competitors is 2.34, providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN) exhibits a P/S ratio of 5.78, which is 147.63% above the industry average. Given its robust revenue growth of 21.25%, this premium appears sustainable.

What is the current P/B ratio for AxoGen Inc (AXGN) as of Mar 02 2026?

As of Mar 02 2026, AxoGen Inc (AXGN) has a P/B ratio of 11.83. This indicates that the market values AXGN at 11.83 times its book value.

What is the current FCF Yield for AxoGen Inc (AXGN) as of Mar 02 2026?

As of Mar 02 2026, AxoGen Inc (AXGN) has a FCF Yield of 0.23%. This means that for every dollar of AxoGen Inc's market capitalization, the company generates 0.23 cents in free cash flow.

What is the current Forward P/E ratio for AxoGen Inc (AXGN) as of Mar 02 2026?

As of Mar 02 2026, AxoGen Inc (AXGN) has a Forward P/E ratio of 620.00. This means the market is willing to pay $620.00 for every dollar of AxoGen Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for AxoGen Inc (AXGN) as of Mar 02 2026?

As of Mar 02 2026, AxoGen Inc (AXGN) has a Forward P/S ratio of 5.78. This means the market is valuing AXGN at $5.78 for every dollar of expected revenue over the next 12 months.

AXGN Valuation